Natural Capsules Limited (NATCAPSUQ) — Announcement | 17 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Independent director resigns from material subsidiary board
💡 Investor Takeaway
The resignation does not affect Natural Capsules' financials but signals potential leadership instability in its subsidiary.

Natural Capsules Limited announced that Independent Director Pramod Kasat resigned from its material unlisted subsidiary Natural Biogenex Private Limited effective August 17, 2026, citing professional commitments. The filing complies with SEBI LODR Regulation 30(9) requirements and includes the resignation letter as Annexure-A. This change reflects a leadership transition in a key subsidiary without material financial impact on the parent company.

📄 View Original Announcement (PDF)

About Natural Capsules Limited (NATCAPSUQ)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹210.25 Cr ROE: -14.2% ROCE: -4.9%

View full NATCAPSUQ stock details →

📡 Get AI alerts when NATCAPSUQ files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATCAPSUQ — Free

📊 More NATCAPSUQ filings

See all NATCAPSUQ filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATCAPSUQ files new disclosures

Track NATCAPSUQ filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATCAPSUQ — Free

Free account · 2 AI queries/day